UNSPSC 51162315: Acetaminophen/chlorpheniramine/phenylpropanolamine/salicylamide
Commodity
Code facts
- Part of
-
-
51000000
-
51160000
- 51162300
-
51160000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51162315
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.
The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.
Read the full definition
The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is a histamine-1 receptor antagonist, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3U6IO1965U.
The European Medicines Agency schedules Chlorphenamine (in maleate form) in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01243MIG. Chlorpheniramine maleate generally arises in the molecular formula C16H19CLN2.C4H4O4. The term 'chlorpheniramine' is a European Pharmacopoeia designation.
The third component of this combination drug an adrenergic agonist with the molecular formula C9H13NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 33RU150WUN, chemically known as 1r,2s-(-)-norephedrine hydrochloride but more generally known as phenylpropanolamine, which bears U.S. National Institutes of Health Compound Identifier 4786. The European Medicines Agency schedules Phenylpropanolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09790MIG.
The term PHENYLPROPANOLAMINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 3, No. 3, 1989, List 29). The World Health Organization schedules phenylpropanolamine in its Anatomical Therapeutic Chemical (ATC) Classification. The forth component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier EM8BM710ZC.
The European Medicines Agency schedules Salicylamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10426MIG. Salicylamide generally arises in the molecular formula C7H7NO2. The term SALICYLAMIDE is an International Non-Proprietary Name or INN.
About UNSPSC 51162315
UNSPSC 51162315 Acetaminophen/chlorpheniramine/phenylpropanolamine/salicylamide is a Commodity code that does not align with the recent state and local solicitations posted under it. The code nominally describes a specific cold and pain relief combination product, but the two opportunities on record — one from Seminole County, Florida, and one from the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) — target naloxone and safe drug deactivation systems (Seminole County) and broader generic multi-source pharmaceuticals and OTC products across participating state and local facilities (MMCAP). Neither opportunity solicits the specific acetaminophen-based combination named in the code. The code shows little activity reflecting its nominal scope, and the posted opportunities appear to be miscoded or represent broader pharmaceutical procurement using an overly narrow classification.
The Seminole County IFB (IFB60459723LAS) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. The MMCAP RFP (S1070000015802), administered by the Minnesota Department of Administration's Office of State Procurement, established multiple contracts for generic pharmaceuticals and OTC products across participating state and local government facilities with a response deadline of March 26, 2026 and contract effectiveness of July 1, 2026. Neither solicitation reflects procurement of the specific product combination the code nominally describes. Business development professionals should verify code placement with issuing bodies before pursuing opportunities tagged to this classification.
Quick answers
What is UNSPSC 51162315?
UNSPSC 51162315 is Acetaminophen/
Which NIGP codes match UNSPSC 51162315?
UNSPSC 51162315 maps to 1 NIGP code, 26948 Expectorants, Antitussives, and Mucolytic Agents.
On GovTribe
See everything under UNSPSC 51162315
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code